Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative S-1 and Cisplatin CCRT for Gastric Adenocarcinoma
NCT03814759Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Dec 2016
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tegafur and cisplatin in gastric adenocarcinoma, sponsored by Yonsei University. Primary endpoint: pathological response rate at 10 weeks. Started Dec 2016; status: completed.
02
Drugs
tegafurcisplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT03814759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814759.